A deep cellular atlas of the human ventral substantia nigra in Parkinson’s identifies a genetic and molecular overlap with Type 2 Diabetes

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Parkinson’s disease (PD) is a complex neurodegenerative disorder characterised by selective neuronal loss. We integrate deep full-length single-nuclei sequencing of the human ventral substantia nigra with genome-wide association studies (GWAS) to reveal genetic and cellular drivers of PD. Genetic risk converges onto AGTR1+ dopaminergic neurons and perineuronal (non-myelinating) oligodendrocytes, both reduced in PD, along with oligodendrocyte precursor cells, with risk enriched among disease-disrupted cellular interactions. AGTR1+ neurons represent a metabolically stressed state, not a distinct cell type, marked by renin-angiotensin system (RAS) and MAPK activation, oxidative stress, and mitochondrial dysfunction. This state is associated with type 2 diabetes (T2D) genetic risk. A GWAS of comorbid PD and T2D identifies significant loci in AGTR1 and TCF7L2, providing a mechanistic link between diseases, while AGTR1+ neurons specifically upregulate RAS and T2D drug targets. Comorbid PD/T2D risk is associated with multiple PD rare variant genes that cause non-Lewy body PD, mechanistically stratifying PD.

Article activity feed